Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00113425 · ClinicalTrials.gov registry record · Phase 2
Non-cutting Laser Therapy in the Treatment of Acne
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT00113425 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 44 participants.
The verdict
NCT00113425, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this research project is to study the effect of non-ablative (non-cutting) laser therapy, a technique that uses laser energy to try to improve the appearance of the skin. This type of laser treatment creates changes in a layer of the skin called the dermis without causing an open wound in the skin. The use of non-ablative laser therapy, together with application of a photo-sensitizer (substance that makes the skin more sensitive to light), may improve the appearance of acne. The idea behind the photo-sensitizer is that it is supposed to make the laser more effective than using just the laser alone. It is not yet clear how much improvement can be seen with these treatments or exactly how the skin's response causes these improvements. In this study, we are interested in learning how well such a laser works to improve the symptoms of acne, as well as how much the photo-sensitizer actually enhances the efficacy of the laser.
Interventions
- DEVICE V-Beam laser, Candela Corp., 595 nm wavelength
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00113425
The ClinicalTrials.gov registry entry for NCT00113425 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which V-Beam laser, Candela Corp., 595 nm wavelength is the first listed.
NCT00113425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00113425 about?
NCT00113425 is a clinical study titled "Non-cutting Laser Therapy in the Treatment of Acne". The purpose of this research project is to study the effect of non-ablative (non-cutting) laser therapy, a technique that uses laser energy to try to improve the appearance of the skin. This type of laser treatment creates changes in a layer of the skin called the dermis without causing an open woun...
What is the current status of trial NCT00113425?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2005-08. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00113425?
The interventions under investigation include: V-Beam laser, Candela Corp., 595 nm wavelength (DEVICE).
Who is sponsoring clinical trial NCT00113425?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.